RecruitingNCT06802731

LivQ-box® Parameters in the Diagnosis of Liver Inflammation

A Multicenter Study on the Application of LivQ-box® Parameters in the Diagnosis of Liver Inflammation in Patients with Non-alcoholic Fatty Liver Disease

Sponsor

Wuxi Hisky Medical Technology Co Ltd

Enrollment

365 participants

Start Date

Jan 1, 2024

Study Type

OBSERVATIONAL

Conditions

Fatty Liver Disease Liver Inflammation

Summary

To evaluate the correlation between LivQ-box® parameters carried by iLivTouch and liver inflammation in patients with NAFLD, as well as the diagnostic value of liver inflammation of different severity levels.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with fatty liver disease and liver inflammation. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.